Myelodysplastic syndromes: the pediatric point of view.
暂无分享,去创建一个
F. Locatelli | A. Pession | E. Maserati | M. Zecca | F. Severi | P. De Stefano | P. Stefano | F. Severi | Franco Locatelli | Andrea Pession | M. Zecca
[1] M. Cazzola,et al. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation. , 1995, Medical and pediatric oncology.
[2] R. Hast,et al. Recombinant Human Erythropoietin for Patients with Myelodysplastic Syndromes (MDS)-When is it Worth While? , 1995 .
[3] M. Cazzola,et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. , 1994, Leukemia.
[4] P. O'Connell,et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. , 1994, The New England journal of medicine.
[5] G. Brodeur. The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. , 1994, The New England journal of medicine.
[6] R. Frenck,et al. Parental origins of chromosome 7 loss in childhood monosomy 7 syndrome. , 1994, Leukemia.
[7] A. Pession,et al. Late effects in children after bone marrow transplantation: a review. , 1993, Haematologica.
[8] J. Buckley,et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] F. Appelbaum,et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. , 1993, Blood.
[10] A. Gratwohl,et al. BONE MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKAEMIAS , 1993, British journal of haematology.
[11] A. List,et al. MANAGEMENT OF MYELODYSPLASTIC SYNDROMES , 1993, British journal of haematology.
[12] J. Hansen,et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.
[13] W. Gradishar,et al. Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. , 1992, Blood.
[14] T. Yamada,et al. Low‐dose etoposide: a potential therapy for myelodysplastic syndromes , 1992, British journal of haematology.
[15] A. Pagliuca,et al. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases , 1992, British journal of haematology.
[16] I. Hann. Myelodysplastic syndromes. , 1992, Archives of disease in childhood.
[17] O. Haas,et al. Experience in pediatric myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.
[18] M. Ogawa,et al. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. List,et al. Biology and pathogenesis of the myelodysplastic syndromes. , 1992, Seminars in oncology.
[20] S. Sullivan,et al. Circulating CD34+ cells: An adverse prognostic factor in the myelodysplastic syndromes , 1992, American journal of hematology.
[21] C. Bloomfield,et al. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. , 1992, Seminars in oncology.
[22] Z. Estrov,et al. Central role of tumour necrosis factor, GM‐CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia , 1992, British journal of haematology.
[23] P. Emanuel,et al. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. , 1991, Experimental hematology.
[24] R. Abels,et al. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. , 1991, Blood.
[25] A. Jacobs. Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia. , 1991, Leukemia.
[26] D. Bowen,et al. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin , 1991, British journal of haematology.
[27] P. O’Connell,et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.
[28] C. Haanen,et al. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia , 1990, Cancer.
[29] S. Raimondi,et al. Myeloid neoplasia in children treated for solid tumours , 1990, The Lancet.
[30] A. Ganser,et al. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. , 1990, Blood.
[31] J. Sklar,et al. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. , 1990, Blood.
[32] B. Cheson,et al. The myelodysplastic syndromes: current approaches to therapy. , 1990, Annals of internal medicine.
[33] X. Thomas,et al. Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns , 1990, American journal of hematology.
[34] S. Thibodeau,et al. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. , 1990, Blood.
[35] A. Baruchel,et al. Monosomy-7 in childhood hemopoietic disorders. , 1990, Leukemia.
[36] R. Storb,et al. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. , 1990 .
[37] T. Hotta. [Management of myelodysplastic syndromes]. , 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[38] L. Luzzatto,et al. Leukaemia is a genetic disorder of somatic cells. , 1990, Haematologica.
[39] M. Worwood,et al. FMS mutations in myelodysplastic, leukemic, and normal subjects. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] N. Day,et al. Leukemia following Hodgkin's disease. , 1990, The New England journal of medicine.
[41] P. Emanuel,et al. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. , 1989, Blood.
[42] J. Caro,et al. Circulating erythropoietin in patients with myelodysplastic syndromes , 1989, British journal of haematology.
[43] A. Bowcock,et al. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7. , 1989, The Journal of clinical investigation.
[44] F. Behm,et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.
[45] M. Sanz,et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. , 1989, Blood.
[46] A. Jacobs. Oncogenes in the myelodysplastic syndrome. , 1989, Blood reviews.
[47] E. Guinan,et al. Bone marrow transplantation for children with myelodysplastic syndromes. , 1989, Blood.
[48] H. Uchino,et al. Conservative treatment of refractory myelodysplastic anemias: a Japanese Cooperative Study. , 1988, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.
[49] F. McCormick,et al. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. , 1988, Leukemia.
[50] R. Parmley,et al. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia. , 1988, Experimental hematology.
[51] D. Rosenthal,et al. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. , 1988, Blood.
[52] B. Czepulkowski,et al. Childhood monosomy 7 revisited , 1988, British journal of haematology.
[53] J. Bennett. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Report of the workshop held in Scottsdale, Arizona, USA, on February 23-25, 1987. Third MIC Cooperative Study Group. , 1988, Cancer genetics and cytogenetics.
[54] K. Sullivan,et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. , 1988, Blood.
[55] D. Heitjan,et al. Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. , 1988, Blood.
[56] A. Ganser,et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial. , 1988, Onkologie.
[57] J. Gmür. [Allogeneic bone marrow transplantation]. , 1988, Therapeutische Umschau. Revue therapeutique.
[58] J. Gutterman,et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. , 1987, The New England journal of medicine.
[59] R. Stanhope,et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function , 1987, British journal of haematology.
[60] Z. Estrov,et al. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] F. Hecht,et al. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia , 1987, Nature.
[62] Z. Estrov,et al. Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission. , 1987, Blood.
[63] M. Tomonaga,et al. Cytogenetic and cytochemical studies on progenitor cells of primary acquired sideroblastic anemia (PASA): involvement of multipotent myeloid stem cells in PASA clone and mosaicism with normal clone. , 1987, Blood.
[64] P. Bierman,et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] J. Klein,et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen , 1987 .
[66] H. Mano,et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.
[67] R. Clark,et al. A randomized trial of 13‐cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome , 1987, British journal of haematology.
[68] A. Jacobs. Human preleukaemia: do we have a model? , 1987, British Journal of Cancer.
[69] R. Simon,et al. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] H. Deeg,et al. Growth and development following marrow transplantation for leukemia. , 1986, Blood.
[71] Galton Da,et al. Myelodysplastic syndromes: natural history and features of prognostic importance. , 1986, Clinics in haematology.
[72] Levin Eg,et al. Secondary myelodysplastic syndromes and leukaemias. , 1986 .
[73] G. Tricot,et al. The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes , 1986, British journal of haematology.
[74] H. Garewal,et al. Management of myelodysplastic syndromes. , 1986 .
[75] Z. Estrov,et al. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. , 1986, Blood.
[76] J. Gabrilove,et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.
[77] W. Carroll,et al. Childhood bone marrow monosomy 7 syndrome: a familial disorder? , 1985, The Journal of pediatrics.
[78] G. Tricot,et al. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis , 1985, British journal of haematology.
[79] D. Machin,et al. Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.
[80] P. Fialkow,et al. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. , 1984, Blood.
[81] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[82] S. Lawler,et al. Monosomy 7 in Childhood: a Myeloproliferative Disorder , 1981, British journal of haematology.
[83] B. Lange,et al. Preleukemia in children. , 1981, The Journal of pediatrics.
[84] D. Poplack,et al. Chronic myelomonocytic leukemia in childhood , 1981, American journal of hematology.
[85] A. Pecking,et al. Refractory anemia with excess of blast cells: Prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients , 1979, Cancer.
[86] A. Carroll,et al. A common progenitor for human myeloid and lymphoid cells , 1978, Nature.
[87] A. Pecking,et al. Refractory Anaemia with Excess of Myeloblasts in the Bone Marrow: a Clinical Trial of Androgens in 90 Patients , 1977, British journal of haematology.
[88] J. Lilleyman,et al. Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine. , 1977, Blood.
[89] A. Chapelle,et al. Defective chemotaxis in monosomy-7 , 1977, Nature.
[90] J. Armata,et al. [Smouldering acute leukemia in a child]. , 1974, Polskie Archiwum Medycyny Wewnetrznej.
[91] S. Lewis,et al. DYSERYTHROPOIESIS AND DYSERYTHROPOIETIC ANAEMIA , 1972, British journal of haematology.
[92] R. Kaufman,et al. Smoldering acute leukemia. , 1963, The New England journal of medicine.
[93] M. Berant,et al. Congenital juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha-2. , 1993, Medical and pediatric oncology.
[94] M. Mangi,et al. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. , 1992, Blood.
[95] D. Horsman,et al. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. , 1990, The American journal of pediatric hematology/oncology.
[96] A. Farrow,et al. Myelodysplasia, chemical exposure, and other environmental factors. , 1989, Leukemia.
[97] H. Heimpel,et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. , 1989, Blood.
[98] Z. Estrov,et al. Juvenile Chronic Myelogenous Leukemia , 1988, The American journal of pediatric hematology/oncology.
[99] J. Klein,et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. , 1987, Blood.
[100] G. Masera,et al. Myelodysplastic Syndromes in Childhood: Report of 21 Patients from Italy and West Germany , 1987, The American journal of pediatric hematology/oncology.
[101] C. Bloomfield,et al. Secondary myelodysplastic syndromes and leukaemias. , 1986, Clinics in haematology.
[102] G. Mufti,et al. Myelodysplastic syndromes: natural history and features of prognostic importance. , 1986, Clinics in haematology.
[103] J. Bennett,et al. Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring system , 1985, Hematological oncology.
[104] Denis R. Miller,et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors , 1984, Cancer.